Serbian Biotech Startup BioEridan Expands Longevity Research with…

Event summary

BioEridan premiered its documentary 'BioEridan: Science Beneath the Surface' in Belgrade on September 15, 2026, followed by a screening at Christ’s College, University of Cambridge.
The documentary highlights BioEridan’s development of underwater Aquafarms for biotechnology research, focusing on longevity science and telomere-related research.
BioEridan is backed by Telekom Srbija Group’s TS Ventures Fund, a €25 million corporate venture capital fund established in 2021.
The event included a UK-Serbia Health, Digital Transformation & Innovation roundtable, aiming to foster collaboration between Serbian and UK scientific and entrepreneurial talent.

The big picture

BioEridan’s journey from Belgrade to Cambridge underscores the growing trend of biotech startups leveraging international partnerships to accelerate research and development. The company’s focus on longevity science aligns with a broader industry shift towards healthy ageing solutions, positioning Serbia as an emerging player in the biotechnology sector. Telekom Srbija Group’s investment through TS Ventures Fund highlights the strategic importance of supporting innovative startups in the region.

What we're watching

International Expansion: How BioEridan’s collaboration with UK institutions will affect its research and commercialization efforts.
Funding and Scaling: Whether TS Ventures Fund’s support will be sufficient for BioEridan to scale its operations and achieve international recognition.
Scientific Breakthroughs: The pace at which BioEridan can develop and commercialize its bioactive ingredients for longevity-focused products.